Coconut-water Sleep Healthy Adults Randomized Trial: What the Evidence Says

Quick Answer

Coconut-water Sleep Healthy Adults Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are guideline, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 guideline, 1 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• In response, this consensus document, developed by the Prevention Council of the Inter-American Society of Cardiology (SIAC-PREVENT), aims to formulate regionally relevant, evidence-based therapeutic recommendations to mitigate cardiovascular risk and improve clinical outcomes in this high-burden population. [Wyss Fernando (2026); evidence level 2]
• This wide range suggests that the true prevalence of diabetes in Latin-America likely exceeds current estimates and that a substantial proportion of individuals live with undiagnosed diabetes receiving no, inadequate, or suboptimal treatment while being exposed to a high risk of micro and macrovascular complications. [Wyss Fernando (2026); evidence level 2]
• Constipation is defined as "a condition characterized by the retention of feces in the large intestine, leading to pellet-like or hard stools, reduced bowel movement frequency, excessive straining, a sense of incomplete evacuation, anorectal blockage, or difficulty in defecation". [Otsubo Yuki (2026); evidence level 2]
• Chronic constipation, which is defined as "a condition in which persistent constipation disrupts daily life and may lead to various physical impairments," has been shown to be associated with reduced survival rates and an increased risk of ischemic stroke and coronary artery disease. [Otsubo Yuki (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For coconut-water sleep healthy adults randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Wyss Fernando (2026). Ibero-American position statement on therapeutic recommendations for the preventive management of cardiovascular complications in latin-American patients with type 2 diabetes mellitus: consensus of the prevention council of the inter-American society of cardiology (SIAC-PREVENT). DOI: 10.1186/s13098-026-02157-5. PMCID: PMC13214458. PMID: 41968371. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13214458/
• Otsubo Yuki (2026). Effects of low-dose medium-chain triglycerides on bowel habit outcomes in Japanese adults prone to constipation: a randomized, double-blind, LCT-controlled crossover trial. DOI: 10.3389/fnut.2026.1746245. PMCID: PMC13015347. PMID: 41889721. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13015347/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.